Avandia Heart Attacks And You
Avandia is a once infamous drug against Type 2 diabetes, the most common type of the disease and the one often seen with obesity. Both Avandia and its rival Actos are drugs that aid the body to make better use of insulin, the digestive hormone that diabetic patients are having trouble with.
However, with the issues pressed and cases filed against GlaxoSmithKline PLC over the widespread injuries they had caused on millions of patients, its controversial drug for diabetics Avandia (rosiglitazone) is as of now unavailable in the market, except for certain restrictions.
Avandia Heart Attacks Are You At Risk ?
Studies have shown that people who use Avandia have increased risk for acquiring heart diseases, Avandia heart attacks, or strokes even in some cases reported broken bones.
It caused hundreds of cases of Avandia heart attacks every month when it was still widely used. If diabetic clients were given Actos instead of Avandia, around 500 heart attacks and more than 300 heart failures would have been undone. Around 304 mortalities were reported during the third quarter of 2009.
As a result of a study published in the New England Journal of Medicine, the commonly prescribed drug Avandia came under the reexamination of the United States’ Food and Drug Administration. According to the study, the drug can lead to heart attacks and even death from cardiovascular causes. The study was conducted from the Cleveland Clinic and was the compilation of research conclusions from 42 other similar studies performed in the past. From the data gathered, researchers recommended that people who use Avandia to treat Type 2 Diabetes mellitus should consult their respective doctors concerning the risks of the medicine, and that the doctors should think about the cardiovascular risks it posed before prescribing it to patients.
Massive Amounts Of Avandia Heart Attacks
Researchers urged doctors to consider other drugs since there are other oral forms of medication that can control the disease and are not known to lead to cardiac problems. One concern that the study pressed is that diabetic patients are already at risk for developing cardiac problems due to the complication brought about by the disease itself, and that taking Avandia will increase their risk for acquiring life threatening side effects. Avandia Heart Attacks where the worst of these side effects.
The Food and Drug Administration’s studies that reviewed the science behind Avandia pointed to larger health risks compared to health benefits. However GlaxoSmithKline said that the study was flawed and more accurate results from their ongoing trials showed that Avandia posed no significant risks to patients’ health specifically their heart and cardiovascular system. These conflicting evidences strengthened the push to continue with the clinical trials.
The public warning came from an analysis of short-term clinical studies that compared other diabetic treatments to an Avandia drug therapy. Results showed that patients who use Avandia increase their risk for heart attacks by 43%, and increase their risk of death by 64% from heart diseases.
Yet upon assessing the overall risk, it was minute. Only 86 heart attacks and 39 mortalities were reported among the 15,560 patients using Avandia, compared with 12,283 patients not taking Avandia that reported with 72 heart attacks and 22 deaths.
Steven Nissen, MD and Kathy Wolski, MPH, study investigators, suggest that susceptible patients can provoke myocardial infarctions (heart attacks), or death from cardiovascular causes when using Avandia after short-term exposure to the drug. Dr. Nissen is the chairperson of Cleveland Clinic’s department of cardiovascular medicine, and the American College of Cardiology’s previous president.
In 1999, the FDA approved the drug Avandia following clinical trials that showed promising effects to decrease blood-sugar levels in patients suffering from diabetes mellitus type 2. Diabetes mellitus can lead to complex complications involving microvascular problems that can further lead to other disabilities such as blindness, loss of sensation, or kidney failure. Heart diseases have also been linked to diabetes.
But according to the trials that awarded the approval of Avandia into the market, it didn’t prove that the drug can actually prevent patients from developing these microvascular complications that worsens the health problem.
University of Washington researcher Bruce M. Psaty, MD, PhD said that Nissen’s study denotes that there’s not enough good reason to prescribe Avandia to patients given the conclusions, in an editorial accompanying the study. Risk of Avandia Heart Attacks where just to great.
Psaty said that the purpose of the drug is to decrease blood sugar levels and in turn stop the occurrence of cardiovascular problems. However since Avandia use is linked to the occurrence of cardiovascular problems, the rationale of using it is diminished and unclear. Although Psaty asked patients who are using Avandia to be careful, he warns them not to immediately withdraw from the drug. They should continue using the drug until they can talk about the issue with their physicians.
Some researchers find it difficult to comprehend why clients and doctors would opt to use Avandia given the widespread issues it claimed, even where there are safer alternatives that are available.
Avandia Heart Attacks Victim seek compensation via Avandia lawsuit settlements. Free Case Review for Avandia heart attacks.